[go: up one dir, main page]

NO931040D0 - Indol- og indazolderivater, fremgangsmaate til fremstilling og anvendelse derav - Google Patents

Indol- og indazolderivater, fremgangsmaate til fremstilling og anvendelse derav

Info

Publication number
NO931040D0
NO931040D0 NO931040A NO931040A NO931040D0 NO 931040 D0 NO931040 D0 NO 931040D0 NO 931040 A NO931040 A NO 931040A NO 931040 A NO931040 A NO 931040A NO 931040 D0 NO931040 D0 NO 931040D0
Authority
NO
Norway
Prior art keywords
indoles
preparing
procedure
indazol
derivatives
Prior art date
Application number
NO931040A
Other languages
English (en)
Other versions
NO931040L (no
Inventor
Shunji Naruto
Yuichi Sugano
Yoshiki Matsui
Toshiyuki Tonohiro
Tsugio Kaneko
Nobuyoshi Iwata
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of NO931040D0 publication Critical patent/NO931040D0/no
Publication of NO931040L publication Critical patent/NO931040L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO93931040A 1992-03-23 1993-03-23 Indol- og indazolderivater, fremgangsmaate til fremstilling og anvendelse derav NO931040L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP6532392 1992-03-23
JP915693 1993-01-22

Publications (2)

Publication Number Publication Date
NO931040D0 true NO931040D0 (no) 1993-03-23
NO931040L NO931040L (no) 1993-09-24

Family

ID=26343823

Family Applications (1)

Application Number Title Priority Date Filing Date
NO93931040A NO931040L (no) 1992-03-23 1993-03-23 Indol- og indazolderivater, fremgangsmaate til fremstilling og anvendelse derav

Country Status (11)

Country Link
EP (1) EP0562832A1 (no)
KR (1) KR930019661A (no)
CN (1) CN1081676A (no)
AU (1) AU3537893A (no)
CA (1) CA2092112A1 (no)
CZ (1) CZ47393A3 (no)
FI (1) FI931291A (no)
HU (1) HU9300828D0 (no)
IL (1) IL105139A0 (no)
NO (1) NO931040L (no)
TW (1) TW226019B (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW263504B (no) * 1991-10-03 1995-11-21 Pfizer
IT1271352B (it) * 1993-04-08 1997-05-27 Boehringer Ingelheim Italia Derivati dell'indolo utili nel trattamento dei disturbi del sistema nervoso centrale
GB9310582D0 (en) * 1993-05-22 1993-07-07 Smithkline Beecham Plc Pharmaceuticals
US5620973A (en) * 1993-11-30 1997-04-15 Takeda Chemical Industries, Ltd. Tetracyclic condensed heterocyclic compounds and their use
ES2098186B1 (es) * 1995-02-09 1998-02-01 Consejo Superior Investigacion Composiciones farmaceuticas a base de aminometilindoles para su aplicacion terapeutica como neuroprotectores en las enfermedades de parkinson y alzheimer.
GB2308362A (en) * 1995-12-19 1997-06-25 Lilly Industries Ltd Pharmaceutical indole derivatives
US6534496B1 (en) 1997-04-17 2003-03-18 Takeda Chemical Industries, Inc. Thermogenic composition and benzazepine thermogenics
NZ510685A (en) 1998-09-30 2003-10-31 Takeda Chemical Industries Ltd Drugs for improving vesical excretory strength
CN1317276C (zh) * 2000-09-29 2007-05-23 中国科学院上海药物研究所 一类吲哚基哌啶类化合物及其制备方法和用途
AU2002367425B2 (en) 2001-12-28 2006-03-09 Takeda Pharmaceutical Company Limited Preventives/remedies for urinary disturbance
TW200621237A (en) 2004-11-01 2006-07-01 Wyeth Corp [(1-h-indazol-3-yl)methyl]phenols and (hydroxyphenyl)(1h-indazol-3-yl)methanones
MX2007006408A (es) 2004-11-29 2007-06-22 Warner Lambert Co Pirazolo[3,4-b]piridinas e indazoles terapeuticos.
AU2007206016A1 (en) 2006-01-13 2007-07-26 Wyeth Sulfonyl substituted 1H-indoles as ligands for the 5-hydroxytryptamine receptors
EP2528911B1 (en) 2010-01-28 2017-10-25 President and Fellows of Harvard College Compositions and methods for enhancing proteasome activity
CA2799154A1 (en) 2010-05-12 2011-11-17 Abbvie Inc. Indazole inhibitors of kinase
PT2707101T (pt) * 2011-05-12 2019-05-30 Proteostasis Therapeutics Inc Reguladores da proteostase
US9849135B2 (en) 2013-01-25 2017-12-26 President And Fellows Of Harvard College USP14 inhibitors for treating or preventing viral infections
WO2015073528A1 (en) 2013-11-12 2015-05-21 Proteostasis Therapeutics, Inc. Proteasome activity enhancing compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2334358A1 (fr) * 1975-12-12 1977-07-08 Sogeras Nouveaux medicaments derives de l'indole
FR2477544A1 (fr) * 1980-03-07 1981-09-11 Pharmindustrie Nouveaux derives de la chloro-3 quinoleine, procedes pour leur preparation, et leur utilisation comme medicaments

Also Published As

Publication number Publication date
TW226019B (no) 1994-07-01
CA2092112A1 (en) 1993-09-24
CZ47393A3 (en) 1993-11-17
NO931040L (no) 1993-09-24
IL105139A0 (en) 1993-07-08
EP0562832A1 (en) 1993-09-29
CN1081676A (zh) 1994-02-09
FI931291A0 (fi) 1993-03-23
AU3537893A (en) 1993-09-30
HU9300828D0 (en) 1993-06-28
KR930019661A (ko) 1993-10-18
FI931291A (fi) 1993-09-24

Similar Documents

Publication Publication Date Title
NO931040L (no) Indol- og indazolderivater, fremgangsmaate til fremstilling og anvendelse derav
NO923371L (no) Framgangsmaate og anordning for etablering av sikker kommunikasjon
NO892083L (no) Fremgangsmaate for fremstilling av arylmetylenyl-derivaterav tiazolidinoner, imidazolidinoner og oksazolidinoner.
NO911020D0 (no) Fremgangsmaate og preparat for koiontoforese.
NO943031D0 (no) Fremgangsmåte og system for understöttende kommunikasjon
DK297089D0 (da) Pyrimidinderivater og fremgangsmaade til fremstilling deraf
NO932662D0 (no) Fremgangsmaate for fremstilling av kitin og kitosan av biomedisinsk kvalitet
IS4244A (is) Aðferð til framleiðslu á Indoline afleiðum og notkun þeirra
NO891866D0 (no) Kromanderivater og fremgangsmaate for fremstilling derav.
DK0635004T3 (da) 4-Diphenylmethylpiperidinderivater og fremgangsmåde til fremstilling deraf
IS1864B (is) Nýjar bensímídasólafleiður sem vinna gegn magasári, aðferðir til að útbúa þær og lyfjablöndur sem innihalda þær
DK69989D0 (da) Benzodioxolderivater og fremgangsmaade til fremstilling deraf
NO892494L (no) Kromanderivater og fremgangsmaate for fremstilling derav.
NO932282D0 (no) Oljeaktig preparat og fremgangsmaate for fremstilling av dette
DK1693A (da) Pyranobenzoxadiazolderivat og fremgangsmaade til fremstilling deraf
NO894103L (no) Kromanderivater og fremgangsmaate for fremstilling derav.
DK530689D0 (da) Adenylcyclasederivater, fremgangsmaade til fremstilling deraf og deres anvendelse
DK0701554T3 (da) Benzisoselen-azolinderivater og -azinderivater, fremgangsmåde til fremstilling heraf og deres terapeutiske anvendelse
NO940130D0 (no) Benzimidazolderivater, fremgangsmaate for deres fremstilling og te rapeutisk anvendelse derav
NO930796D0 (no) Glykopeptidderivater, fremgangsmaate for deres fremstilling og farmasoeytiske midler inneholdende disse
DK103889D0 (da) Benzimidazooe1,2-caachinazoliner og fremgangsmaade til fremstilling heraf
NO934227D0 (no) Pyrrolderivater, fremgangsm}te for deres fremstilling og terapeutiske anvendelse
NO891630D0 (no) Fremgangsmaate og anordning for fremstilling av diafragmer.
DK291188D0 (da) 5-methoxyalkylammonium-tetrahydrofuran- og -tetrahydrothiophen-derivater, fremgangsmaade til fremstilling deraf og laegemidler indeholdende saadanne derivater
NO893963D0 (no) 3-aryloksymetyl-cefalosporinderivater og fremgangsmaate til fremstilling derav.